Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Review

Sanjeev A Francis¹  Caroline Daly²  Ravi V Shah³  Raymond Y Kwong³  Bobak Heydari³  Siddique Abbasi³ 

[1] Cardiology Division, Department of Medicine, Massuchusetts General Hospital, Boston, MA, USA;Cardiology Division, St. James’ Hospital, Dublin, Ireland;Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA;

关键词: Cardiovascular Magnetic Resonance;    Cardiac Resynchronization Therapy;    Cardiac Imaging;    Suspected Coronary Artery Disease;    Transcatheter Aortic Valve Replacement;   

DOI  :  10.1186/1532-429X-15-52

 received in 2013-06-03, accepted in 2013-06-03,  发布年份 2013

来源: Springer

【 摘 要 】

With the need for healthcare cost-containment, increased scrutiny will be placed on new medical therapeutic or diagnostic technologies. Several challenges exist for a new diagnostic test to demonstrate cost-effectiveness. New diagnostic tests differ from therapeutic procedures due to the fact that diagnostic tests do not generally directly affect long-term patient outcomes. Instead, the results of diagnostic tests can influence management decisions for patients and by this route, diagnostic tests indirectly affect long-term outcomes. The benefits from a specific diagnostic technology depend therefore not only on its performance characteristics, but also on other factors such as prevalence of disease, and effectiveness of existing treatments for the disease of interest. We review the concepts and theories of cost-effectiveness analyses (CEA) as they apply to diagnostic tests in general. The limitations of CEA across different study designs and geographic regions are discussed, and we also examine the strengths and weakness of the existing publications where CMR was the focus of CEA compared to other diagnostic options.

【 授权许可】

Unknown   
© Francis et al.; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.